EUVIMEDEUVIMED felfedezése
Open access

Enhanced prostatic Esr1 + luminal epithelial cells in the absence of SRD5A2

Christina Sharkey iD, Xingbo Long, Ra'ad Al-Faouri iD, Douglas Strand iD, Aria F Olumi iD, Zongwei Wang iD

The Journal of Pathology · 2024-07 · 263 (3) · 300-314

DOI: 10.1002/path.6283 ↗

At a glance

Journal article in The Journal of Pathology, published online on 2024-04-12. Written by Christina Sharkey and 5 co-authors. Institution: Department of Surgery, Division of Urologic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Major MEDLINE topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase, Epithelial Cells, Estrogen Receptor alpha, Membrane Proteins. Cited 13 times so far (Crossref); 51 references. The full text is freely available in PubMed Central. Funded by: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbsztraktSubjectsBibliográfiai adatokCiteRelated studies

Abstract (original language)

Steroid 5α reductase 2 (SRD5A2) converts testosterone to dihydrotestosterone and is crucial for prostatic development. 5α reductase inhibitors (5ARI) reduce prostate size in benign prostate hyperplasia (BPH) and ameliorate lower urinary tract symptoms secondary to BPH. However, the mechanisms of 5ARI functioning are still not fully understood. Here, we used a Srd5a2 −/− mouse model and employed single‐cell RNA sequencing to explore the impact of SRD5A2 absence on prostate cellular heterogeneity. Significant alterations in luminal epithelial cell (LE) populations were observed, alongside an increased proportion and proliferative phenotype of estrogen receptor 1 (ESR1) + LE2 cells, following an SRD5A2‐independent ESR1 differentiation trajectory. LE2 cells exhibited enhanced estrogen response gene signatures, suggesting an alternative pathway for prostate growth when SRD5A2 is absent. Human prostate biopsy analysis revealed an inverse correlation between the expressions of SRD5A2 and LE2 markers (ESR1/PKCα), and an inverse correlation between SRD5A2 and the clinical efficiency of 5ARI. These findings provide insights into 5ARI resistance mechanisms and potential alternative therapies for BPH‐related lower urinary tract symptoms. © 2024 The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

3-Oxo-5-alpha-Steroid 4-DehydrogenaseEpithelial CellsEstrogen Receptor alphaMembrane ProteinsProstateProstatic HyperplasiaAnimalsHumansMaleMice5-alpha Reductase InhibitorsCell DifferentiationCell ProliferationDisease Models, AnimalLower Urinary Tract SymptomsMice, Knockout

Author keywords

Medical Therapy of Prostate Symptoms (MTOPS)Srd5a2−/− micebenign prostatic hyperplasiaestrogen receptor 1luminal epithelial cellsingle‐cell RNA‐sequencingsteroid 5α reductase 2 (SRD5A2)

Substances

3-Oxo-5-alpha-Steroid 4-Dehydrogenase5-alpha Reductase InhibitorsESR1 protein, humanEsr1 protein, mouseEstrogen Receptor alphaMembrane ProteinsSRD5A2 protein, humanSrd5a2 protein, mouse

Authors and institutions

  • Department of Surgery, Division of Urologic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China.
  • State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China.
  • Department of Urology, UT Southwestern Medical Center, Dallas, TX, USA.

ORCID profiles: Christina Sharkey, Ra'ad Al-Faouri, Douglas Strand, Aria F Olumi, Zongwei Wang

Funding

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Cite

APA

Sharkey, C., Long, X., Al-Faouri, R., Strand, D., Olumi, A. F., & Wang, Z. (2024). Enhanced prostatic Esr1 + luminal epithelial cells in the absence of SRD5A2. The Journal of Pathology, 263(3), 300-314. https://doi.org/10.1002/path.6283

Vancouver

Sharkey C, Long X, Al-Faouri R, Strand D, Olumi AF, Wang Z. Enhanced prostatic Esr1 + luminal epithelial cells in the absence of SRD5A2. The Journal of Pathology. 2024;263(3):300-314. doi:10.1002/path.6283

BibTeX
@article{Sharkey2024,
  author = {Sharkey, Christina and Long, Xingbo and Al-Faouri, Ra'ad and Strand, Douglas and Olumi, Aria F and Wang, Zongwei},
  title = {Enhanced prostatic Esr1 + luminal epithelial cells in the absence of SRD5A2},
  journal = {The Journal of Pathology},
  year = {2024},
  volume = {263},
  number = {3},
  pages = {300--314},
  doi = {10.1002/path.6283}
}
Start for free →